Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages 8651
Publisher
MDPI AG
Online
2020-11-17
DOI
10.3390/ijms21228651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
- (2020) Seyyed Abolghasem Ghadami et al. BIOMACROMOLECULES
- Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
- (2020) Tamta Arakhamia et al. CELL
- Interaction of Aβ42 with Membranes Triggers the Self-Assembly into Oligomers
- (2020) Siddhartha Banerjee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel tau filament fold in corticobasal degeneration
- (2020) Wenjuan Zhang et al. NATURE
- Proteome-wide observation of the phenomenon of life on the edge of solubility
- (2020) Giulia Vecchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structures of α-synuclein filaments from multiple system atrophy
- (2020) Manuel Schweighauser et al. NATURE
- Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
- (2020) Thomas C. T. Michaels et al. Nature Chemistry
- Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
- (2020) Deqiang Han et al. Frontiers in Cellular Neuroscience
- Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
- (2020) Nurul Husna Ibrahim et al. Frontiers in Pharmacology
- The Toxicity and Polymorphism of β-Amyloid Oligomers
- (2020) Ya-ru Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
- (2020) Ryan Limbocker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
- (2020) Francesco A. Aprile et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval
- (2020) Martin Tolar et al. Alzheimers Research & Therapy
- Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism
- (2020) Ryan Limbocker et al. Communications Biology
- Single-particle cryo-EM at atomic resolution
- (2020) Takanori Nakane et al. NATURE
- Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
- (2020) Sara Linse et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
- (2020) Thomas C. T. Michaels et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
- (2019) Ryan Limbocker et al. Nature Communications
- The proteostasis network and its decline in ageing
- (2019) Mark S. Hipp et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
- (2019) Benjamin Falcon et al. NATURE
- Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer’s brain
- (2019) Gunnar Brinkmalm et al. BRAIN
- S100 Proteins in Alzheimer’s Disease
- (2019) Joana S. Cristóvão et al. Frontiers in Neuroscience
- Pharmacological Potential of Cilostazol for Alzheimer’s Disease
- (2019) Kenjiro Ono et al. Frontiers in Pharmacology
- Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
- (2019) Tom Scheidt et al. Science Advances
- Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF
- (2019) Ting Yang et al. ANNALS OF NEUROLOGY
- β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction?
- (2019) Dennis Selkoe LANCET NEUROLOGY
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
- (2019) Yu Yamazaki et al. Nature Reviews Neurology
- Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts
- (2019) Camila Fabiani et al. Frontiers in Cellular Neuroscience
- A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
- (2019) Ebrima Gibbs et al. Scientific Reports
- Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
- (2019) Jie Liu et al. Frontiers in Molecular Neuroscience
- Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils
- (2019) Erika Y. Choi et al. Biomolecules & Therapeutics
- Promising disease-modifying therapies for Parkinson’s disease
- (2019) Valina L. Dawson et al. Science Translational Medicine
- Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
- (2019) Darren J. Schofield et al. NEUROBIOLOGY OF DISEASE
- Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease
- (2019) Fernando. L. Pagan et al. JAMA Neurology
- Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
- (2018) Michele Perni et al. ACS Chemical Biology
- Stabilization and characterization of cytotoxic Aβ40 oligomers isolated from an aggregation reaction in the presence of zinc ions
- (2018) Benedetta Mannini et al. ACS Chemical Neuroscience
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice
- (2018) Tomomi Kiyota et al. JOURNAL OF NEUROIMMUNOLOGY
- The Aβ protofibril selective antibody mAb158 prevents accumulation of Aβ in astrocytes and rescues neurons from Aβ-induced cell death
- (2018) Sofia Söllvander et al. Journal of Neuroinflammation
- Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
- (2018) Johnny Habchi et al. Nature Chemistry
- Aβ dimers induce behavioral and neurochemical deficits of relevance to early Alzheimer's disease
- (2018) Laila Abdel-Hafiz et al. NEUROBIOLOGY OF AGING
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro
- (2018) Hidenobu Shozawa et al. NEUROSCIENCE LETTERS
- Inhibition of amyloid beta fibril formation by monomeric human transthyretin
- (2018) Kanchan Garai et al. PROTEIN SCIENCE
- The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregation
- (2018) Joana S. Cristóvão et al. Science Advances
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms
- (2018) Sofia Giorgetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
- (2018) Stina Tucker et al. JOURNAL OF ALZHEIMERS DISEASE
- Structures of filaments from Pick’s disease reveal a novel tau protein fold
- (2018) Benjamin Falcon et al. NATURE
- SAR by kinetics for drug discovery in protein misfolding diseases
- (2018) Sean Chia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
- (2018) Diana L. Price et al. Scientific Reports
- Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
- (2018) Jacqueline P. Robbins et al. Frontiers in Neuroscience
- Autophagy and the cell biology of age-related disease
- (2018) Andrew M. Leidal et al. NATURE CELL BIOLOGY
- A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology
- (2018) Hongjun Fu et al. NATURE NEUROSCIENCE
- Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
- (2018) Andreas Weihofen et al. NEUROBIOLOGY OF DISEASE
- Pathways of cellular proteostasis in aging and disease
- (2017) Courtney L. Klaips et al. JOURNAL OF CELL BIOLOGY
- Shaping proteostasis at the cellular, tissue, and organismal level
- (2017) Ambre J. Sala et al. JOURNAL OF CELL BIOLOGY
- Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
- (2017) Gabriel Gustafsson et al. Journal of Neuroinflammation
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis
- (2017) Hoau-Yan Wang et al. NEUROBIOLOGY OF AGING
- Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication
- (2017) Anna Munke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
- (2017) Michele Perni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
- (2017) Giuliana Fusco et al. SCIENCE
- Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity
- (2017) Benedetta Mannini et al. Frontiers in Molecular Neuroscience
- Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
- (2017) Francesco A. Aprile et al. Science Advances
- Protein misfolding in neurodegenerative diseases: implications and strategies
- (2017) Patrick Sweeney et al. Translational Neurodegeneration
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
- (2017) David I. Finkelstein et al. Acta Neuropathologica Communications
- Identification of Antihypertensive Drugs Which Inhibit Amyloid-β Protein Oligomerization
- (2017) Wei Zhao et al. JOURNAL OF ALZHEIMERS DISEASE
- Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules
- (2016) Mackenzie D. Martin et al. ACS Chemical Biology
- Sulindac Sulfide Induces the Formation of Large Oligomeric Aggregates of the Alzheimer’s Disease Amyloid-β Peptide Which Exhibit Reduced Neurotoxicity
- (2016) Elke Prade et al. BIOCHEMISTRY
- Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations
- (2016) Sara Cappelli et al. BIOLOGICAL CHEMISTRY
- AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
- (2016) Francesco Simone Ruggeri et al. CURRENT PHARMACEUTICAL DESIGN
- Neurodegeneration and the Heat Shock Protein 70 Machinery: Implications for Therapeutic Development
- (2016) Sarah N. Fontaine et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- The Luminescent Oligothiophene p-FTAA Converts Toxic Aβ1–42Species into Nontoxic Amyloid Fibers with Altered Properties
- (2016) Livia Civitelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clusterin Binds to Aβ1–42Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation
- (2016) Marten Beeg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson's Disease with Fatigue: Clinical Characteristics and Potential Mechanisms Relevant to α-Synuclein Oligomer
- (2016) Li-Jun Zuo et al. Journal of Clinical Neurology
- Membrane-bound tetramer and trimer Aβ oligomeric species correlate with toxicity towards cultured neurons
- (2016) Metta K. Jana et al. JOURNAL OF NEUROCHEMISTRY
- A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer’s mouse model via an HSF1-mediated mechanism
- (2016) B Wang et al. MOLECULAR PSYCHIATRY
- First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
- (2016) Dale B. Schenk et al. MOVEMENT DISORDERS
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity inDrosophila
- (2016) Pedro Fernandez-Funez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
- (2016) Johnny Habchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
- (2016) Céline Galvagnion et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo aspects of protein folding and quality control
- (2016) D. Balchin et al. SCIENCE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
- (2016) Paolo Arosio et al. Nature Communications
- Nanoscale studies link amyloid maturity with polyglutamine diseases onset
- (2016) F. S. Ruggeri et al. Scientific Reports
- A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimers disease
- (2016) R. Freer et al. Science Advances
- An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A 42 aggregates linked with Alzheimers disease
- (2016) J. Habchi et al. Science Advances
- Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases
- (2016) Elisa Evangelisti et al. Scientific Reports
- Influence of the β-Sheet Content on the Mechanical Properties of Aggregates during Amyloid Fibrillization
- (2015) Francesco Simone Ruggeri et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Biology of Proteostasis in Aging and Disease
- (2015) Johnathan Labbadia et al. Annual Review of Biochemistry
- Structural, morphological, and functional diversity of amyloid oligomers
- (2015) Leonid Breydo et al. FEBS LETTERS
- Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function
- (2015) Junji Egawa et al. JOURNAL OF PHYSIOLOGY-LONDON
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation
- (2015) Serene W. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular chaperones and neuronal proteostasis
- (2015) Heather L. Smith et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases
- (2015) Prajwal Ciryam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
- (2015) Samuel I A Cohen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity
- (2014) Benedetta Mannini et al. ACS Chemical Biology
- Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis
- (2014) Michela Guglielmotto et al. Autophagy
- Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation
- (2014) Yanqin Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
- (2014) Eduardo Coelho-Cerqueira et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Metabolic Control of Autophagy
- (2014) Lorenzo Galluzzi et al. CELL
- Structure and Mechanism of Action of Tau Aggregation Inhibitors
- (2014) Katryna Cisek et al. Current Alzheimer Research
- Anti-amyloidogenic effects of ID1201, the ethanolic extract of the fruits of Melia toosendan, through activation of the phosphatidylinositol 3-kinase/Akt pathway
- (2014) Hanbyeol Park et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease
- (2014) Yukiko Hori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid Beta-Derived Diffusible Ligands (ADDLs) Induce Abnormal Expression of Insulin Receptors in Rat Hippocampal Neurons
- (2014) Xin Liu et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The amyloid state and its association with protein misfolding diseases
- (2014) Tuomas P. J. Knowles et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ID1201, the ethanolic extract of the fruit of Melia toosendan ameliorates impairments in spatial learning and reduces levels of amyloid beta in 5XFAD mice
- (2014) Woo-Hyun Cho et al. NEUROSCIENCE LETTERS
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
- (2014) Nicholas J. Izzo et al. PLoS One
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
- (2014) Nicholas J. Izzo et al. PLoS One
- The structured core domain of B-crystallin can prevent amyloid fibrillation and associated toxicity
- (2014) G. K. A. Hochberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural evolution and membrane interactions of Alzheimer's amyloid-beta peptide oligomers: New knowledge from single-molecule fluorescence studies
- (2014) Robin D. Johnson et al. PROTEIN SCIENCE
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease
- (2014) Marc Brehme et al. Cell Reports
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity
- (2013) Cristina Cecchi et al. BIOPHYSICAL CHEMISTRY
- Brain amyloid-β oligomers in ageing and Alzheimer’s disease
- (2013) Sylvain E. Lesné et al. BRAIN
- Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
- (2013) M. L. Hebron et al. HUMAN MOLECULAR GENETICS
- Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
- (2013) Fernando L. Palhano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Proliferation of amyloid- 42 aggregates occurs through a secondary nucleation mechanism
- (2013) S. I. A. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Widespread Aggregation and Neurodegenerative Diseases Are Associated with Supersaturated Proteins
- (2013) Prajwal Ciryam et al. Cell Reports
- First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
- (2012) Robert Lai et al. Alzheimers & Dementia
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein
- (2012) Paola Cavaliere et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships
- (2012) Francesco Bemporad et al. CHEMISTRY & BIOLOGY
- Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
- (2012) S. K. Kalia et al. CNS & Neurological Disorders-Drug Targets
- Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
- (2012) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-β Neurotoxicity
- (2012) Marie E. Benoit et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic β-Amyloid-42 Fibril Formation
- (2012) Heiko Kroth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
- (2012) Samuel I.A. Cohen et al. JOURNAL OF MOLECULAR BIOLOGY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
- (2012) Ji Won Um et al. NATURE NEUROSCIENCE
- Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers
- (2012) B. Mannini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer’s Disease
- (2012) Margarita C. Dinamarca et al. Frontiers in Physiology
- Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes
- (2011) Thomas L. Williams et al. BIOCHEMICAL JOURNAL
- Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques
- (2011) J-Y Kim et al. CELL DEATH AND DIFFERENTIATION
- Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms
- (2011) Marcus O. W. Grimm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses
- (2011) Satoko Matsumura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Metastability of Native Proteins and the Phenomenon of Amyloid Formation
- (2011) Andrew J. Baldwin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Single Molecule Tracking Analysis Reveals That the Surface Mobility of Amyloid Oligomers Is Driven by Their Conformational Structure
- (2011) Martino Calamai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism
- (2011) J. Ojha et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular chaperones in protein folding and proteostasis
- (2011) F. Ulrich Hartl et al. NATURE
- Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
- (2011) Jan Bieschke et al. Nature Chemical Biology
- Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice
- (2011) Juhi Ojha et al. PLoS One
- Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
- (2011) Smita Majumder et al. PLoS One
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ANS Binding Reveals Common Features of Cytotoxic Amyloid Species
- (2010) Benedetta Bolognesi et al. ACS Chemical Biology
- Size-dependent neurotoxicity of β-amyloid oligomers
- (2010) Paulius Cizas et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Detergent-like Interaction of Congo Red with the Amyloid β Peptide
- (2010) Christofer Lendel et al. BIOCHEMISTRY
- Surface-induced phase separation of a sphingomyelin/cholesterol/ganglioside GM1-planar bilayer on mica surfaces and microdomain molecular conformation that accelerates Aβ oligomerization
- (2010) Yanli Mao et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid β through Three Independent Pathways
- (2010) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
- (2010) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
- (2010) Vanessa Villard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A causative link between the structure of aberrant protein oligomers and their toxicity
- (2010) Silvia Campioni et al. Nature Chemical Biology
- Inhibition of PTP1B by Trodusquemine (MSI-1436) Causes Fat-specific Weight Loss in Diet-induced Obese Mice
- (2010) Kristen A. Lantz et al. Obesity
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Stabilization of neurotoxic Alzheimer amyloid- oligomers by protein engineering
- (2010) A. Sandberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid β-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process
- (2009) Erik Hellstrand et al. ACS Chemical Neuroscience
- Phenolic Compounds Prevent Alzheimer’s Pathology through Different Effects on the Amyloid-β Aggregation Pathway
- (2009) Tsuyoshi Hamaguchi et al. AMERICAN JOURNAL OF PATHOLOGY
- Structure−Activity Relationship of Cyanine Tau Aggregation Inhibitors
- (2009) Edward Chang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Collagen VI protects neurons against Aβ toxicity
- (2009) Jason S Cheng et al. NATURE NEUROSCIENCE
- Curcumin inhibits aggregation of α-synuclein
- (2008) Neeraj Pandey et al. ACTA NEUROPATHOLOGICA
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS
- (2008) Bernadett Kalmar et al. JOURNAL OF NEUROCHEMISTRY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
- (2008) Igor F. Tsigelny et al. PLoS One
- Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
- (2003) Mary P. Lambert et al. JOURNAL OF NEUROCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now